Figure 2.
Type of anticoagulant treatment at the time of index stroke, at hospital discharge, and at 3 years of follow-up. VKA, vitamin K antagonist; FXa, Factor Xa inhibitor; DTI, direct thrombin inhibitor; pNone, no previous anticoagulant treatment; pVKA, previously treated with vitamin K antagonist; pFXa, previously treated with Factor Xa inhibitor; pDTI, previously treated with direct thrombin inhibitor; 3yVKA, VKA at 3 years of follow-up; 3yFXa, Factor Xa inhibitor at 3 years of follow-up; 3yDTI, direct thrombin inhibitor at 3 years of follow-up.